BioCare is excited to announce that Octapharma’s NUWIQ is now available.

Nuwiq is the first and only recombinant FVIII produced in human cells without chemical modification.

It is indicated in children and adults with Hemophilia A for on-demand treatment & control of bleeding disorders, perioperative management of bleeding and routine prophylaxis to reduce the frequency of bleeding episodes.

It is not indicated for the treatment of von Willebrand Disease.

To order this product, call BioCare at 1-800-304-3064.